News Image

Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update

Provided By GlobeNewswire

Last update: Aug 12, 2024

Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully implanted Acclaim® cochlear implant; Maintains goal of starting Pivotal Clinical Trial by end of the year

Read more at globenewswire.com

ENVOY MEDICAL INC

NASDAQ:COCH (2/21/2025, 8:10:29 PM)

1.48

-0.04 (-2.89%)



Find more stocks in the Stock Screener

Follow ChartMill for more